CP USA, LLC – Trademark Portfolio

Entity Type: 16

CP USA, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 16 (Paper Goods) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include HINGEPAC. The owner is based in PHILADELPHIA, PA.

3001 RED LION ROAD

PHILADELPHIA, PA 19114

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CP USA, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

16
Paper Goods (2 filings)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does CP USA, LLC have?

CP USA, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 cancelled.

What trademark classes does CP USA, LLC file in?

CP USA, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 16 (Paper Goods), Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 16 covers paper and cardboard; printed matter; bookbinding material; photographs; stationery.

What are CP USA, LLC's most well-known trademarks?

CP USA, LLC's registered trademark portfolio includes well-known marks such as HINGEPAC. These are among 1 currently registered trademark in the portfolio.

What is CP USA, LLC's trademark registration success rate?

CP USA, LLC has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.